Skip to Content
Morningstar

TransMedics Group Inc TMDX

Morningstar Rating
Unlock
Stock XNAS Rating as of
$87.24 −0.62 (0.71%)
View Full Chart
As of Delayed Price Post-Trading: $86.00 −1.00
Unlock our analysis with Morningstar Investor
Start Free Trial

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

View History
TMDX is trading at a 29% discount.
Price
$87.63
Fair Value
$151.68
Uncertainty
Extreme
1-Star Price
$633.87
5-Star Price
$95.92
Economic Moat
Tkmgf
Capital Allocation
—
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TMDX is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$87.86
Day Range
$85.84–90.15
52-Week Range
$36.42–99.63
Bid/Ask
$87.09 / $87.24
Market Cap
$2.87 Bil
Volume/Avg
692,257 / 758,951

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
11.82
Dividend Yield (Trailing)
—
Dividend Yield (Forward)
—
Total Yield
—

Company Profile

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
584
Website
https://www.transmedics.com

Comparables

Valuation

View More
Metric
TMDX
NARI
SWAV
Price/Earnings (Normalized)
 —415.7884.30
Price/Book Value
 20.924.8118.12
Price/Sales
 11.824.4517.14
Price/Cash Flow
 91.2266.0052.17
Price/Earnings
TMDX
NARI
SWAV

Financial Strength

Metric
TMDX
NARI
SWAV
Quick Ratio
 8.342.4310.61
Current Ratio
 9.303.0911.76
Interest Coverage
 −2.63−56.9926.24
Quick Ratio
TMDX
NARI
SWAV

Profitability

Metric
TMDX
NARI
SWAV
Return on Assets (Normalized)
 −1.28%5.07%19.87%
Return on Equity (Normalized)
 −4.30%6.37%35.18%
Return on Invested Capital (Normalized)
 −1.70%3.35%22.54%
Return on Assets
TMDX
NARI
SWAV
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Medical Devices Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesCqlpbkypHchkjkd$183.8 Bil
SYK
Stryker CorpWsnbypptqJhws$127.8 Bil
MDT
Medtronic PLCZxsnbydjFjybns$105.0 Bil
BSX
Boston Scientific CorpLvjpsgcfVfbkgy$99.9 Bil
EW
Edwards Lifesciences CorpWwcmyydtcxPrgkxc$52.5 Bil
DXCM
DexCom IncXvqkhgnvbhQslbn$51.9 Bil
ZBH
Zimmer Biomet Holdings IncMlpsyvrrskWmyjt$24.9 Bil
ALGN
Align Technology IncJtpsppjvTsgys$22.6 Bil
PHG
Koninklijke Philips NV ADRYslvmwvhQkhjwq$18.2 Bil
PODD
Insulet CorpMxmvxdmblYpwjyhr$11.6 Bil

Sponsor Center